DE69627748D1 - Zusammensetzung zur Behandlung von Nierenversagen - Google Patents

Zusammensetzung zur Behandlung von Nierenversagen

Info

Publication number
DE69627748D1
DE69627748D1 DE69627748T DE69627748T DE69627748D1 DE 69627748 D1 DE69627748 D1 DE 69627748D1 DE 69627748 T DE69627748 T DE 69627748T DE 69627748 T DE69627748 T DE 69627748T DE 69627748 D1 DE69627748 D1 DE 69627748D1
Authority
DE
Germany
Prior art keywords
composition
treatment
kidney failure
amino acids
enteral composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69627748T
Other languages
English (en)
Other versions
DE69627748T2 (de
Inventor
Shen-Youn Chang
Dave C Madsen
Susan L Trimbo
Hugh N Tucker
Diana Twyman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Societe des Produits Nestle SA
Nestle SA
Original Assignee
Societe des Produits Nestle SA
Nestle SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe des Produits Nestle SA, Nestle SA filed Critical Societe des Produits Nestle SA
Application granted granted Critical
Publication of DE69627748D1 publication Critical patent/DE69627748D1/de
Publication of DE69627748T2 publication Critical patent/DE69627748T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • External Artificial Organs (AREA)
DE69627748T 1995-06-06 1996-06-04 Zusammensetzung zur Behandlung von Nierenversagen Expired - Lifetime DE69627748T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US470985 1995-06-06
US08/470,985 US5728678A (en) 1995-06-06 1995-06-06 Method and composition for providing nutrition to a renal failure patient

Publications (2)

Publication Number Publication Date
DE69627748D1 true DE69627748D1 (de) 2003-06-05
DE69627748T2 DE69627748T2 (de) 2004-03-25

Family

ID=23869841

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69627748T Expired - Lifetime DE69627748T2 (de) 1995-06-06 1996-06-04 Zusammensetzung zur Behandlung von Nierenversagen

Country Status (7)

Country Link
US (1) US5728678A (de)
EP (1) EP0747395B1 (de)
JP (1) JPH0920678A (de)
AT (1) ATE239037T1 (de)
CA (1) CA2177195C (de)
DE (1) DE69627748T2 (de)
ES (1) ES2198459T3 (de)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995029252A1 (en) * 1994-04-21 1995-11-02 Ivan Lubomirov Stoilov Oral preparation for patients with chronic renal insufficiency and other protein metabolic diseases
DE19539574A1 (de) * 1995-10-25 1997-04-30 Boehringer Mannheim Gmbh Zubereitungen und Verfahren zur Stabilisierung biologischer Materialien mittels Trocknungsverfahren ohne Einfrieren
US6054421A (en) * 1997-09-23 2000-04-25 Scimed Life Systems, Inc. Medical emulsion lubricant
US6281175B1 (en) 1997-09-23 2001-08-28 Scimed Life Systems, Inc. Medical emulsion for lubrication and delivery of drugs
DK1044017T3 (da) * 1998-01-05 2008-12-08 Univ Johns Hopkins Kosttilskud til dialysepatienter
AU2217399A (en) * 1998-01-07 1999-07-26 Mark E. Jarmel Promoting mobilization and catabolism of lipids
US6194379B1 (en) 1998-05-01 2001-02-27 Abbott Laboratories Elemental enteral formula
US6288116B1 (en) * 1998-05-13 2001-09-11 Novartis Nutrition Ag Method of administration of a nutritional product to a person having renal failure
US6149924A (en) * 1998-07-20 2000-11-21 Biomed Research & Technologies, Inc. Composition for enhancing lipid production, barrier function, hydrogen peroxide neutralization, and moisturization of the skin
US6610206B1 (en) 1998-10-20 2003-08-26 Advanced Renal Technologies Buffered compositions for dialysis
US7670491B2 (en) * 1998-10-20 2010-03-02 Advanced Renal Technologies Buffered compositions for dialysis
ES2187115T3 (es) * 1999-01-20 2003-05-16 Nutricia Nv Preparado para lactantes.
ATE298205T1 (de) * 1999-01-29 2005-07-15 Sportmedizin Team Vertriebs Gm Zusammensetzung zur leistungsförderung bei sportlicher tätigkeit, ihre herstellung und verwendung als diätetisches lebensmittel
CA2371696C (en) * 1999-04-29 2005-11-15 Societe Des Produits Nestle S.A. Composition for an infant formula having a low threonine content
GB9923048D0 (en) * 1999-09-29 1999-12-01 Nestle Sa Composition comprising casein protein and whey protein
ATE303077T1 (de) * 1999-04-29 2005-09-15 Nestle Sa Süssmolkeprotein enthaltende säuglingsnahrung
AU6275800A (en) * 1999-07-16 2001-02-05 Mallinckrodt, Inc. Inhibition of renal uptake of molecules that are potentially damaging for the kidney
EP1218039B1 (de) * 1999-09-22 2009-02-18 Advanced Renal Technologies Anwendung eines dialysats mit hohem zitratgehalt
US6833350B2 (en) * 2000-02-04 2004-12-21 Nestec S.A. Method for maintaining or improving the synthesis of mucins
NZ520605A (en) * 2000-02-04 2004-06-25 Nestle Sa Oral administration of a nutritional supplement containing at least 5.5% threonine increase mucin synthesis
US6592863B2 (en) * 2000-08-22 2003-07-15 Nestec S.A. Nutritional composition
US6995166B1 (en) 2000-09-27 2006-02-07 Everett Laboratories, Inc. Method and composition for supplementation of nutritional deficiencies in renal patients
US7696219B2 (en) * 2000-09-27 2010-04-13 Everett Laboratories, Inc. Method and composition for supplementation of nutritional deficiences in renal patients
WO2002069964A1 (en) * 2001-03-05 2002-09-12 Ernest Stephen P Enteral formulation
TWI328450B (en) * 2001-06-08 2010-08-11 Rikagaku Kenkyusho Agents capable of raising body temperature for food and medical uses,which comprise amino acids
US20030105104A1 (en) * 2001-11-27 2003-06-05 Burzynski Stanislaw R. Formulation of amino acids and riboflavin useful to reduce toxic effects of cytotoxic chemotherapy
JP4355578B2 (ja) * 2002-04-09 2009-11-04 エーザイ・アール・アンド・ディー・マネジメント株式会社 リボフラビン系化合物を含む医薬
JP4970694B2 (ja) 2002-12-02 2012-07-11 株式会社明治 持続性筋肉疲労改善剤
ES2485311T3 (es) * 2004-04-09 2014-08-13 N.V. Nutricia Fórmula concentrada líquida
US20080058410A1 (en) * 2004-07-23 2008-03-06 Dpi Solutions, Inc. Composition for Stabilizing Vitamin C in Water Phase and Method for Stabilizing C Using Thereof
FR2875680B1 (fr) * 2004-09-29 2010-08-20 Veronique Marie-Pierre Peyrusson Compose dietetique pour combattre le syndrome metabolique
WO2007084059A1 (en) 2006-01-20 2007-07-26 Bjoerk Inger A food composition comprising amino acids
CA2701179C (en) * 2007-10-04 2021-03-16 Nestec S.A. Compositions and methods for enhancing cognitive function
WO2009113845A1 (en) 2008-03-12 2009-09-17 N.V. Nutricia High protein liquid enteral nutritional composition
CN103054046B (zh) 2007-12-05 2015-04-22 荷兰纽迪希亚公司 高能量液体肠营养组合物
EP2165713B1 (de) * 2008-09-19 2012-11-14 Nestec S.A. Molke und Verbesserung der Thymusfunktion
CN102238947B (zh) 2008-12-05 2015-01-14 味之素株式会社 营养组合物
WO2011021926A1 (en) 2009-08-21 2011-02-24 N.V. Nutricia Regulating the amino acid pool used for the acute-phase protein synthesis
IT1397446B1 (it) * 2010-01-12 2013-01-10 Professional Dietetics Srl Compositions comprising amino acids for prevention and/or treatment of renal disorders.
US20110274678A1 (en) * 2010-05-07 2011-11-10 Kourosh Dibadj Beverage
US20210176999A1 (en) 2011-04-17 2021-06-17 Omega Foods, LLC Prepared foods having high efficacy omega-6/omega-3 balanced polyunsaturated fatty acids
WO2013133691A1 (en) * 2012-03-09 2013-09-12 N.V. Nutricia Liquid nutritional composition comprising free amino acids
JP6555122B2 (ja) * 2013-02-26 2019-08-07 味の素株式会社 栄養組成物
EP2994123B1 (de) 2013-05-08 2020-04-08 Gambro Lundia AB Dialyseformulierung
US10130603B2 (en) 2013-11-05 2018-11-20 Colgate-Palmolive Company Methods and compositions for improving kidney function
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
JP7266581B2 (ja) 2017-08-14 2023-04-28 アクセラ・ヘルス・インコーポレイテッド 肝疾患の治療のためのアミノ酸組成物
US11484579B2 (en) 2017-11-29 2022-11-01 Edgar L Hull Vitamins and alpha keto acid compositions for use in a treatment program for chronic kidney disease patients
EP3716966A4 (de) 2017-11-29 2021-08-18 Hull, Edgar, L., Jr. Alpha-ketosäurezusammensetzungen zur behandlung von hypoalbuminämie
US20190240180A1 (en) * 2018-02-08 2019-08-08 Nestec Sa Mct-based nutrition blend for providing health benefits in companion animals
US10806169B2 (en) * 2018-05-15 2020-10-20 Kate Farms, Inc. Hydrolyzed pea protein-based nutrient composition
US10596136B2 (en) 2018-06-20 2020-03-24 Axcella Health Inc. Compositions and methods for the treatment of fat infiltration in muscle
US11412771B2 (en) * 2019-04-12 2022-08-16 The Amino Company LLC Composition to improve athletic performance by supporting muscle protein synthesis and mental focus
ES2926903T3 (es) * 2019-10-02 2022-10-31 Hull Edgar L Jr Vitaminas y composiciones de alfa-cetoácidos para su uso en un programa de tratamiento para pacientes con enfermedad renal crónica
US20220400704A1 (en) * 2019-11-29 2022-12-22 Morinaga Milk Industry Co., Ltd. Composition for Enteral Intake
CL2019003831A1 (es) 2019-12-24 2020-06-05 Univ Antofagasta Producto alimenticio tipo snack hiperproteico conteniendo proteínas con alto valor biológico (avb) para pacientes que sufren hemodiálisis.
KR102574938B1 (ko) * 2021-01-20 2023-09-07 라이프 샐러드 주식회사 신장 투석 환자용 쉐이크 파우더 및 그 제조 방법
KR102574939B1 (ko) * 2021-01-20 2023-09-07 라이프 샐러드 주식회사 신장 비투석 환자용 쉐이크 파우더 및 그 제조 방법
WO2023066832A1 (en) * 2021-10-21 2023-04-27 Société des Produits Nestlé S.A. Composition

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7004843A (de) * 1969-04-03 1970-10-06
US4357343A (en) * 1981-06-26 1982-11-02 Baxter Travenol Laboratories, Inc. Nutritional composition for management of renal failure
US4898879A (en) * 1981-06-29 1990-02-06 Baxter International Inc. Nurtitional composition for management of hepatic failure
US4678807A (en) * 1984-03-01 1987-07-07 Baxter Travenol Laboratories, Inc. Method for directed visceral metabolism of medium chain triglycerides
US4920098A (en) * 1986-09-17 1990-04-24 Baxter International Inc. Nutritional support or therapy for individuals at risk or under treatment for atherosclerotic vascular, cardiovascular, and/or thrombotic diseases
US5294642A (en) * 1989-11-30 1994-03-15 Clintec Nutrition Co. Method for improving ventilation during sleep and treating sleep related ventilation abnormalities
DE4002204A1 (de) * 1990-01-26 1991-08-01 Westfalen Milchwerke Diaetetisches nahrungsmittel fuer patienten mit niereninsuffizienz
US5571783A (en) * 1993-03-09 1996-11-05 Clintec Nutrition Company Composition and method for treating patients with hepatic disease
US5378722A (en) * 1993-12-03 1995-01-03 Clintec Nutrition Co. Nutritional compositions for management of nitrogen metabolism
US5576287A (en) * 1994-04-29 1996-11-19 Wake Forest University Method for treating acute renal disease and failure

Also Published As

Publication number Publication date
DE69627748T2 (de) 2004-03-25
CA2177195A1 (en) 1996-12-07
CA2177195C (en) 2012-04-17
JPH0920678A (ja) 1997-01-21
EP0747395B1 (de) 2003-05-02
ATE239037T1 (de) 2003-05-15
US5728678A (en) 1998-03-17
ES2198459T3 (es) 2004-02-01
EP0747395A1 (de) 1996-12-11

Similar Documents

Publication Publication Date Title
DE69627748D1 (de) Zusammensetzung zur Behandlung von Nierenversagen
DE69625691T2 (de) Verabreichung von peptidylheterocyclen zur behandlung von thrombin in zusammenhang stehenden krankheiten
DE69305105T3 (de) Zusammensetzungen zur oralen Nahrungsmittelaufnahme mit verbessertem Geschmack
DK46789D0 (da) 3-indolpyrodruesyrederivater og farmaceutisk anvendelse deraf
DK0961552T3 (da) Næringstilskud til pædiatriske patienter
NO881542D0 (no) Kondisjoneringsvaesker av tann- eller benstoff.
NO933044D0 (no) Fremgangsmaate for behandling av osteoporose
DE69002201D1 (de) Formulierung zur behandlung der nierenkrankheiten.
ATE267180T1 (de) Phosphorderivate zur behandlung von aids
DE69631656D1 (de) Debromhymenialdisin und verwandte verbindungen zur behandlung von osteoarthritis
BG102814A (en) New derivatives of carboxylic acid, their preparation and application
BG97123A (bg) Производни на човешка, стимулирана от жлъчните соли, липаза и фармацевтични състави на тяхна основа
DE59611383D1 (de) Darreichungsform zur applikation von pharmazeutischen wirkstoffen und hilfsstoffen und verfahren zur herstellung derselben
DE69314590D1 (de) Behandlung von Proteinhaltigen Körperflüssigkeiten
DE3878812T2 (de) Omega-3-fettsaeuren zur behandlung von traumatischen verwundungen.
DE3769910D1 (de) Verwendung von n, n'-bis-l-aminosaeure-l-cystinpeptiden in aminosaeure-praeparaten fuer orale und parenterale ernaehrung.
ATE249837T1 (de) Caspase 8-inhibitoren zur immunsuppression
ATE251912T1 (de) Verwendung des erythropoietins zur behandlung von rheumatoider arthritis
DE68908445T2 (de) Mittel zur Behandlung von Lebererkrankungen.
DE69602040D1 (de) Verfahren zur Herstellung von Alkylbenzoylchlorid
DE68905479D1 (de) Transdermate magensafthemmende wirkstoffe zur behandlung von magen-darm-erkrankungen.
RU94036168A (ru) Применение панкреатина (экстракт поджелудочной железы) в качестве реактива для определения переваримости белка в желудке грудных детей
DE69927591D1 (de) Behandlung von nierenkolik mit gaba-analogen
ATE95061T1 (de) Schmiermittelzubereitung zur behandlung von rheuma.
ATE74767T1 (de) Arzneimittelzusammensetzung zur behandlung des lungenverstopfens.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition